Virtual
Treating Multiple Sclerosis with a Breakthrough Drug
This conversation was livestreamed on September 9, 2020.
Help support the OHSU Department of Neurology and the innovative research in the fight against multiple sclerosis. MAKE A GIFT TODAY.
For more information about supporting OHSU’s groundbreaking work in multiple sclerosis, please contact:
Maddy Abulencia, Director of Development
[email protected]
For years, OHSU has been on the front lines in attacking MS. Now, thanks to innovative “high-risk” research funded by philanthropy, a breakthrough drug that could stimulate critical myelin repair will start clinical trials within a year, raising expectations of MS patients worldwide. Hear the powerful story of the doctor who wouldn’t give up, and a grateful patient who has new hope thanks to research her family has generously supported.
Presenters:
Laura Wieden
OHSU Patient and Philanthropist
Dennis Bourdette, M.D., FANA, FAAN
Professor Emeritus of Neurology
OHSU School of Medicine
